145 related articles for article (PubMed ID: 25940811)
1. Safety of Novel Amino-5-laevulinate Photosensitizer Precursors in Photodynamic Therapy for Healthy Human Skin.
Neittaanmäki-Perttu N; Neittaanmäki E; Pölönen I; Snellman E; Grönroos M
Acta Derm Venereol; 2016 Jan; 96(1):108-10. PubMed ID: 25940811
[No Abstract] [Full Text] [Related]
2. A randomized intraindividual comparative study of methyl-5-aminolaevulinate vs. 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp.
Serra-Guillén C; Nagore E; Bancalari E; Kindem S; Sanmartín O; Llombart B; Requena C; Serra-Guillén I; Calomarde L; Diago A; Bernia E; Guillén C
Br J Dermatol; 2018 Dec; 179(6):1410-1411. PubMed ID: 30019337
[No Abstract] [Full Text] [Related]
3. Pulse-Daylight-Photodynamic Therapy in Combination with Corticosteroid and Brimonidine Tartrate for Multiple Actinic Keratoses: A Randomized Clinical Trial.
Wiegell SR; Johansen UB; Wulf HC
Acta Derm Venereol; 2019 Feb; 99(2):242-243. PubMed ID: 30250962
[No Abstract] [Full Text] [Related]
4. Late erythema after photodynamic therapy to the face.
Misra A; Maybury K; Eltigani TA
Plast Reconstr Surg; 2006 Jun; 117(7):2522-3. PubMed ID: 16772986
[No Abstract] [Full Text] [Related]
5. Hexyl-5-aminolaevulinate 0·2% vs. methyl-5-aminolaevulinate 16% daylight photodynamic therapy for treatment of actinic keratoses: results of a randomized double-blinded pilot trial.
Neittaanmäki-Perttu N; Grönroos M; Karppinen TT; Tani TT; Snellman E
Br J Dermatol; 2016 Feb; 174(2):427-9. PubMed ID: 26011755
[No Abstract] [Full Text] [Related]
6. Factors influencing pain and efficacy of topical photodynamic therapy: a retrospective study.
Lydon E; Dawe RS; Ibbotson SH
Br J Dermatol; 2019 Jan; 180(1):205-206. PubMed ID: 30216404
[No Abstract] [Full Text] [Related]
7. Transcutaneous electrical nerve stimulation for pain relief during photodynamic therapy of actinic keratoses.
Halldin CB; Paoli J; Sandberg C; Ericson MB; Wennberg AM
Acta Derm Venereol; 2008; 88(3):311-3. PubMed ID: 18480950
[No Abstract] [Full Text] [Related]
8. Microbiological effect of photodynamic therapy (PDT) in healthy volunteers: a comparative study using methyl aminolaevulinate and hexyl aminolaevulinate cream.
Yung A; Stables GI; Fernandez C; Williams J; Bojar RA; Goulden V
Clin Exp Dermatol; 2007 Nov; 32(6):716-21. PubMed ID: 17953640
[TBL] [Abstract][Full Text] [Related]
9. Simulated-daylight photodynamic therapy with BF-200 aminolaevulinic acid for actinic keratosis: assessment of the efficacy and tolerability in a retrospective study.
Kellner C; Bauriedl S; Hollstein S; Reinhold U
Br J Dermatol; 2015 Apr; 172(4):1146-8. PubMed ID: 25244353
[No Abstract] [Full Text] [Related]
10. Ameluz for actinic keratoses.
Med Lett Drugs Ther; 2016 Dec; 58(1509):155-156. PubMed ID: 27906150
[No Abstract] [Full Text] [Related]
11. Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythema.
Mikolajewska P; Iani V; Juzeniene A; Moan J
Br J Dermatol; 2009 Nov; 161(5):1173-9. PubMed ID: 19785604
[TBL] [Abstract][Full Text] [Related]
12. Methyl aminolaevulinate photodynamic therapy in practice: treatment protocol.
Foley P
Australas J Dermatol; 2005 Feb; 46 Suppl 3():S14; discussion S23-5. PubMed ID: 15859304
[No Abstract] [Full Text] [Related]
13. Peripheral facial palsy after topical photodynamic therapy for facial actinic keratoses.
Gemigniani F; Bodet D; González-Llavona B; García-Patos V
J Am Acad Dermatol; 2014 Sep; 71(3):e90-2. PubMed ID: 25128142
[No Abstract] [Full Text] [Related]
14. Daylight photodynamic therapy with methyl-aminolevulinate for the treatment of actinic cheilitis.
Fai D; Romanello E; Brumana MB; Fai C; Vena GA; Cassano N; Piaserico S
Dermatol Ther; 2015; 28(6):355-68. PubMed ID: 26179312
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.
Dirschka T; Radny P; Dominicus R; Mensing H; Brüning H; Jenne L; Karl L; Sebastian M; Oster-Schmidt C; Klövekorn W; Reinhold U; Tanner M; Gröne D; Deichmann M; Simon M; Hübinger F; Hofbauer G; Krähn-Senftleben G; Borrosch F; Reich K; Berking C; Wolf P; Lehmann P; Moers-Carpi M; Hönigsmann H; Wernicke-Panten K; Helwig C; Foguet M; Schmitz B; Lübbert H; Szeimies RM;
Br J Dermatol; 2012 Jan; 166(1):137-46. PubMed ID: 21910711
[TBL] [Abstract][Full Text] [Related]
16. Correlations between photoactivable porphyrins' fluorescence, erythema and the pain induced by PDT on normal skin using ALA-derivatives.
Barge J; Glanzmann T; Zellweger M; Salomon D; van den Bergh H; Wagnières G
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):683-93. PubMed ID: 24284128
[TBL] [Abstract][Full Text] [Related]
17. Topical photodynamic therapy: a new tool in cosmetic dermatology.
Touma DJ; Gilchrest BA
Semin Cutan Med Surg; 2003 Jun; 22(2):124-30. PubMed ID: 12877231
[TBL] [Abstract][Full Text] [Related]
18. 5-Aminolevulinic acid photodynamic therapy versus methyl aminolevulinate photodynamic therapy for inflammatory acne vulgaris.
Gold MH
J Am Acad Dermatol; 2008 Feb; 58(2 Suppl):S60-2. PubMed ID: 18191717
[No Abstract] [Full Text] [Related]
19. Photodynamic therapy.
Larkö O
Australas J Dermatol; 2005 Feb; 46 Suppl 3():S1-2; discussion S23-5. PubMed ID: 15859298
[No Abstract] [Full Text] [Related]
20. Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.
Wiegell SR; Stender IM; Na R; Wulf HC
Arch Dermatol; 2003 Sep; 139(9):1173-7. PubMed ID: 12975159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
